Gene · 54363
Papers4,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Next-generation health monitoring: The role of nanomaterials in 3D-printed wearable devices. | Mater Today (Kidlington) | 2025 | 41919093 | PubTator, text mining | PubMed |
| Clinically friendly smart hydrogel boosts cuproptosis and PD-L1 upregulation to enhance anti-tumor immunotherapy. | Mater Today Bio | 2025 | 41625384 | PubTator, text mining | PubMed |
| A conceptual enzyme-cell therapy model to aid microplastic clearance from the vitreous humor. | Front Bioeng Biotechnol | 2025 | 41608139 | PubTator, text mining | PubMed |
| Interdisciplinary Nanomaterials for Biomedical Imaging and Sensing Applications. | Nanomaterials (Basel) | 2025 | 41511218 | PubTator, text mining | PubMed |
| Non-Fullerene Organic Semiconductor ITIC as a Redox Mediator in Electrochemical Glucose Biosensors. | Sensors (Basel) | 2025 | 41471530 | PubTator, text mining | PubMed |
| Morphology-controlled Mn oxide nanowire/ZIF-8 composites with multi-enzyme activity for glucose oxidase detection. | Mikrochim Acta | 2025 | 41429963 | PubTator, text mining | PubMed |
| Chrysanthemum-like Fe-Co LDH with peroxidase mimicking activity for visual and photothermal determination of H2O2 and glucose. | Anal Methods | 2025 | 41328450 | PubTator, text mining | PubMed |
| Functions and applications of enzymes in nucleic acid nanotechnology. | J Nanobiotechnology | 2025 | 41327310 | PubTator, text mining | PubMed |
| Self-Assembled Spatially Confined Mo-Based Nanoreactor for Multimechanistic Tumor Therapy Driven by Self-Cascade Catalysis. | ACS Nano | 2025 | 41311256 | PubTator, text mining | PubMed |
| A ZIF-8-Based High-Performance Glucose Electrochemical Detection Platform Constructed Using a Multi-Layer Interface Optimization Strategy. | Sensors (Basel) | 2025 | 41305271 | PubTator, text mining | PubMed |
| Advances in Impedimetric Biosensors: Current Applications and Future Directions. | Micromachines (Basel) | 2025 | 41302764 | PubTator, text mining | PubMed |
The Combination of Enzymes in the Enhancement of Fibre-Enriched Product Quality: Effects of the Interactions of Dietary Fibre, Gluten Proteins, and Starch Granules on Dough Rheological Properties and Bubble Dynamics. | Foods | 2025 | 41300119 | PubTator, text mining | PubMed |
| Preparation of Hydrogel by Crosslinking and Multi-Dimensional Applications. | Gels | 2025 | 41294581 | PubTator, text mining | PubMed |
| CD24-targeted cystine and glucose oxidase cascade catalytic nanosystem triggers disulfidptosis in neuroblastoma. | Mater Today Bio | 2025 | 41281650 | PubTator, text mining | PubMed |
| Regulating SLC7A11/GSH/GPX4 axis by glucose dyshomeostasis to simultaneously promote disulfidptosis, cuproptosis and ferroptosis. | Bioact Mater | 2025 | 41268342 | PubTator, text mining | PubMed |
| Pt@Tei Nanozyme: An Antibiotic-Derived Peroxidase Mimic for Sensitive Smartphone-Based Glucose Biosensing. | ACS Appl Bio Mater | 2025 | 41216704 | PubTator, text mining | PubMed |
| shRNAI: A deep neural network for the design of highly potent shRNAs. | Mol Ther Nucleic Acids | 2025 | 41216425 | PubTator, text mining | PubMed |
| Synergistic cascade nanozyme of Zr-TPY-Fe/cys/Au for self-augmented chemodynamic therapy in TNBC cells. | Chem Commun (Camb) | 2025 | 41212079 | PubTator, text mining | PubMed |
| Nano-delivery systems for photothermal/starvation therapy and enhanced ferroptosis-immunotherapy. | J Mater Chem B | 2025 | 41212075 | PubTator, text mining | PubMed |
| Dual-Responsive Nanodelivery System Synergizes Elevation in Hypoxia with PD-L1 Blocking to Activate Systemic Immunity and Inhibit Distant Tumors. | ACS Appl Mater Interfaces | 2025 | 41211720 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54363/papers?page=13